Y-Intercept (HK)
UTHR icon

Y-Intercept (HK)’s United Therapeutics UTHR Stock Holding History

Y-Intercept (HK)’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.85M Sell
8,946
-5,325
-37% -$2.75M 0.11% 245
2026
Q2 		$7.73M Buy
+14,271
New +$8.04M 0.15% 154
2025
Q3 		– Sell
-17,315
Closed -$4.98M – 2075
2025
Q2 		$4.98M Buy
17,315
+13,160
+317% +$3.93M 0.12% 221
2025
Q1 		$1.28M Sell
4,155
-2,015
-33% -$691K 0.09% 322
2024
Q4 		$2.18M Buy
+6,170
New +$2.27M 0.15% 185
2024
Q1 		– Sell
-7,344
Closed -$1.61M – 1783
2023
Q4 		$1.61M Buy
7,344
+5,927
+418% +$1.37M 0.15% 184
2023
Q3 		$320K Buy
+1,417
New +$326K 0.03% 739
2023
Q2 		– Sell
-2,195
Closed -$492K – 1743
2023
Q1 		$492K Buy
+2,195
New +$541K 0.06% 540
2022
Q1 		– Sell
-3,372
Closed -$729K – 974
2021
Q4 		$729K Sell
3,372
-591
-15% -$116K 0.17% 173
2021
Q3 		$731K Buy
3,963
+1,738
+78% +$342K 0.13% 243
2021
Q2 		$399K Buy
+2,225
New +$424K 0.1% 326

Other funds holding UTHR

AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Atwood & Palmer
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
Polaris Capital Management
Polaris Capital Management Boston, Massachusetts $953M AUM 27.74% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Livforsakringsbolaget Skandia
Livforsakringsbolaget Skandia Stockholm, Sweden $3.02B AUM 43.19% 1-Year Est. Return
Nepsis Inc
Nepsis Inc Minneapolis, Minnesota $317M AUM 37.22% 1-Year Est. Return
Vilga Financial Planning
Vilga Financial Planning Fair Lawn, New Jersey $168M AUM 23.03% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Y-Intercept (HK)'s UTHR Position: Q3 2026 in Review

Y-Intercept (HK) reduced its United Therapeutics (UTHR) stake by 37% in Q3 2026, selling an estimated $2.75M and leaving 8,946 shares worth $4.85M. The position accounts for 0.11% of the portfolio, ranked #245.

Y-Intercept (HK) first reported a position in UTHR in Q2 2021 and has held it in 11 quarters since. The position peaked at $7.73M in Q2 2026. 131 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Y-Intercept (HK) held 8,946 shares of United Therapeutics worth $4.85M as of Q3 2026.
  • Y-Intercept (HK) sold 5,325 United Therapeutics shares in Q3 2026, an estimated $2.75M.
  • United Therapeutics made up 0.11% of Y-Intercept (HK)'s portfolio in Q3 2026, its #245 holding.
  • Y-Intercept (HK) first reported a position in United Therapeutics in Q2 2021 and has held it in 11 quarters since.
  • Y-Intercept (HK)'s United Therapeutics position peaked at $7.73M in Q2 2026.
  • 131 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.